Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

117
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
117

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updates in clinical science: Alcohol-related hepatitis.

Journal of hepatology·2026
Same author

Trends in mortality and years of life lost among patients with cirrhosis and hepatocellular carcinoma in France, 2011-2023: a nationwide retrospective population-based study.

The Lancet regional health. Europe·2026
Same author

Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin.

Diabetes & metabolism·2026
Same author

Success of transition to adult care in patients with pediatric-onset chronic liver disease.

Journal of pediatric gastroenterology and nutrition·2026
Same author

Does a patient who needs portal vein embolization (PVE) to proceed to major hepatectomy (MH) have the same hepatic functional reserve than a patient with no preoperative PVE?

Hepatobiliary surgery and nutrition·2026
Same author

Risk prediction model for high-grade dysplasia in resected pancreatic mucinous cystic neoplasms: a nomogram-based approach.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026
Same journal

Body composition's effect on the bone-vascular axis of osteoporosis discovered in AI-based CT analysis of COPD patients.

European radiology·2026
Same journal

ESR Essentials: pelvic floor imaging-practice recommendations by the European Society of Urogenital Radiology.

European radiology·2026
Same journal

STIR or T2-Dixon? A false dilemma in musculoskeletal MRI.

European radiology·2026
Same journal

ESR Essentials: uterine cancers-practice recommendations by the European Society of Urogenital Radiology.

European radiology·2026
Same journal

Adjunctive quantification for more reproducible amyloid PET interpretation.

European radiology·2026
Same journal

APEX-NET: automated pancreatic evaluation network using early non-contrast CT.

European radiology·2026
See all related articles

Related Experiment Video

Updated: Jul 11, 2025

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI
05:37

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI

Published on: October 20, 2023

1.4K

Hepatic fat quantification in dual-layer computed tomography using a three-material decomposition algorithm.

Emilie Demondion1, Olivier Ernst2, Alexandre Louvet3

  • 1Medical Imaging Department, Lille University Hospital, 2 Avenue Oscar-Lambret, Lille, France. emiliedemondion@yahoo.fr.

European Radiology
|November 13, 2023
PubMed
Summary
This summary is machine-generated.

Dual-layer CT (DL-CT) accurately quantifies hepatic fat, showing strong correlation with MRI. This technology enables opportunistic detection of hepatic steatosis, aiding early intervention for metabolic liver disease.

Keywords:
Fatty liverNon-alcoholic fatty liver diseaseRadiography (dual-energy scanned projection)Tomography (X-ray computed)

More Related Videos

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

6.8K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K

Related Experiment Videos

Last Updated: Jul 11, 2025

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI
05:37

Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI

Published on: October 20, 2023

1.4K
Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

6.8K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.2K

Area of Science:

  • Radiology
  • Medical Imaging
  • Hepatology

Background:

  • Hepatic steatosis, or fatty liver disease, is a growing health concern.
  • Accurate quantification of liver fat is crucial for diagnosis and management.
  • Magnetic Resonance Imaging (MRI) is a reference standard but can be costly and time-consuming.

Purpose of the Study:

  • To evaluate a novel three-material decomposition algorithm for hepatic fat quantification using dual-layer computed tomography (DL-CT).
  • To compare DL-CT derived fat fraction with MRI reference standard in a large patient cohort.
  • To assess the diagnostic performance of DL-CT for detecting hepatic steatosis.

Main Methods:

  • Retrospective analysis of 104 patients with both MRI and DL-CT exams.
  • Blind positioning of regions of interest (ROIs) in the liver by two independent readers.
  • Analysis of fat fraction agreement using intraclass correlation coefficients (ICC), R², and Bland-Altman plots.
  • Calculation of sensitivity, specificity, and predictive values for steatosis detection (≥5% fat).

Main Results:

  • Excellent correlation between DL-CT and MRI for hepatic fat fraction (ICC=0.99, R²≈0.95) across all perfusion phases.
  • Good diagnostic performance for hepatic steatosis detection: sensitivity 89-91%, specificity 75-80%.
  • Positive predictive values ranged from 78-93%, and negative predictive values from 82-86%.

Conclusions:

  • The three-material decomposition algorithm in DL-CT provides reliable hepatic fat quantification, correlating well with MRI.
  • DL-CT is accurate for detecting hepatic steatosis (≥5% fat).
  • DL-CT facilitates opportunistic detection of hepatic steatosis during scans for other indications, enabling early intervention for metabolic liver disease.